IDH1/2 mutated gliomas show distinct epigenetic profiles, characterised by a high frequency of methylated CpG islands, the “CpG island methylator phenotype” (CIMP) (Watanabe et al., 2009). This evidence concerns the gene IDH1 and glioma.